Valuation PharmaEssentia Corporation LUXEMBOURG S.E.
Stocks
261280523
US7169722037
Biotechnology & Medical Research
|
End-of-day quote
LUXEMBOURG S.E.
22/10/2026
|
5-day change | 1st Jan Change | ||
| 35.60 USD | -1.66% |
|
-4.30% | +163.44% |
Company Valuation: PharmaEssentia Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 78,065 | 143,840 | 114,578 | 204,725 | 173,829 | 480,741 | - | - |
| Change | - | 84.26% | -20.34% | 78.68% | -15.09% | 176.56% | - | - |
| Enterprise Value (EV) 1 | 75,148 | 133,629 | 94,995 | 183,725 | 153,423 | 457,693 | 446,499 | 480,741 |
| Change | - | 77.82% | -28.91% | 93.4% | -16.49% | 198.32% | -2.45% | 7.67% |
| P/E | -27.1x | -98.6x | -179x | 69.3x | 34.6x | 44x | 27.2x | 17.5x |
| PBR | 19.1x | 11.2x | 4.79x | 7.45x | 5.46x | 11x | 8.53x | - |
| PEG | - | 1.8x | 3x | -0x | 0.5x | 0x | 0.4x | 0.3x |
| Capitalization / Revenue | 119x | 49.9x | 22.4x | 21x | 11.1x | 17.8x | 11.6x | 7.2x |
| EV / Revenue | 114x | 46.4x | 18.6x | 18.9x | 9.81x | 16.9x | 10.8x | 7.2x |
| EV / EBITDA | -29x | -74.2x | -57.8x | 87.3x | 28.8x | 34.5x | 19.3x | 14.2x |
| EV / EBIT | -26.6x | -65.9x | -49.6x | 106x | 31.1x | 36.4x | 20.1x | 14.5x |
| EV / FCF | -29.7x | -73.5x | -49.8x | 102x | 41.7x | 44.3x | 40.8x | 14.3x |
| FCF Yield | -3.37% | -1.36% | -2.01% | 0.98% | 2.4% | 2.26% | 2.45% | 7% |
| Dividend per Share 2 | - | - | - | 0.8936 | 1.352 | 4 | 2.35 | 6 |
| Rate of return | - | - | - | 0.18% | 0.32% | 0.34% | 0.2% | 0.52% |
| EPS 2 | -8.773 | -3.932 | -1.568 | 7.214 | 12.25 | 26.35 | 42.57 | 66.4 |
| Distribution rate | - | - | - | 12.4% | 11% | 15.2% | 5.52% | 9.04% |
| Net sales 1 | 656.5 | 2,882 | 5,106 | 9,735 | 15,635 | 27,072 | 41,504 | 66,730 |
| EBITDA 1 | -2,595 | -1,800 | -1,645 | 2,104 | 5,327 | 13,267 | 23,103 | 33,770 |
| EBIT 1 | -2,822 | -2,028 | -1,913 | 1,736 | 4,928 | 12,563 | 22,252 | 33,246 |
| Net income 1 | -2,811 | -1,375 | -623.8 | 2,966 | 5,045 | 10,523 | 17,963 | 28,045 |
| Net Debt 1 | -2,917 | -10,211 | -19,582 | -21,000 | -20,406 | -23,048 | -34,242 | - |
| Reference price 2 | 238.02 | 387.49 | 281.07 | 499.59 | 423.70 | 1,160.00 | 1,160.00 | 1,160.00 |
| Nbr of stocks (in thousands) | 327,980 | 371,210 | 407,644 | 409,783 | 410,264 | 414,432 | - | - |
| Announcement Date | 02/03/22 | 01/03/23 | 27/02/24 | 26/02/25 | 03/03/26 | - | - | - |
1TWD in Million2TWD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 18.38x | 6.48x | 12.88x | 1.62% | 63.29B | |
| 30.22x | 7.94x | 26.49x | 0.05% | 54.89B | |
| 36.58x | 6.5x | 19.41x | 0.88% | 53.28B | |
| 35.46x | 3.44x | 14.83x | -.--% | 45.81B | |
| 50.32x | 5.82x | 31.95x | -.--% | 43.46B | |
| -19.48x | 188.5x | -20.74x | -.--% | 40.23B | |
| 29.02x | 8.23x | 21.28x | 0.37% | 33.45B | |
| 27.38x | 5.77x | 14.95x | -.--% | 23.7B | |
| 32.79x | 5.99x | 20.16x | -.--% | 23.76B | |
| Average | 26.74x | 26.52x | 15.69x | 0.32% | 42.43B | |
| Weighted average by Cap. | 26.71x | 25.51x | 15.93x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 6446 Stock
- 261280523 Stock
- Valuation PharmaEssentia Corporation
Select your edition
All financial news and data tailored to specific country editions
